MedPageToday
MedPage Today) — A shorter radiotherapy (RT) course proved its mettle in early-stage breast cancer in terms of lymphedema risk, without negatively impacting survival outcomes, according to a phase III trial from France.
In the HypoG-01 study…
Read More
Lymphedema Risk No Higher With 3-Week RT Regimen in Early Breast Cancer
Alejandro Fetzer
10:05
MedPage Today) — A shorter radiotherapy (RT) course proved its mettle in early-stage breast cancer in terms of lymphedema risk, without negatively impacting survival outcomes, according to a phase III trial from France. In the HypoG-01 study…
